Literature DB >> 27295271

Long-term follow-up of patients with relapsed or refractory non-Hodgkin's lymphoma receiving allogeneic stem cell transplantation.

C S Link1, F Mies1,2, J Scheele1, M Kramer1, J Schetelig1, R Ordemann1, M Hänel2, M Bornhäuser1, G Ehninger1, F Kroschinsky1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27295271     DOI： 10.1038/bmt.2016.165

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

1.  Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single center.

Authors:  M Loirat; P Chevallier; C Leux; A Moreau; C Bossard; T Guillaume; T Gastinne; J Delaunay; N Blin; B Mahé; V Dubruille; K Augeul-Meunier; P Peterlin; H Maisonneuve; P Moreau; N Juge-Morineau; H Jardel; M Mohty; P Moreau; S Le Gouill
Journal:  Ann Oncol       Date:  2014-11-12       Impact factor: 32.976

2.  Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome.

Authors:  P Corradini; A Dodero; L Farina; R Fanin; F Patriarca; R Miceli; P Matteucci; M Bregni; R Scimè; F Narni; E Pogliani; A Locasciulli; R Milani; C Carniti; A Bacigalupo; A Rambaldi; F Bonifazi; A Olivieri; A M Gianni; C Tarella
Journal:  Leukemia       Date:  2007-06-28       Impact factor: 11.528

3.  Allogeneic SCT for relapsed composite and transformed lymphoma using related and unrelated donors: long-term results.

Authors:  K M Ramadan; J M Connors; A J Al-Tourah; K W Song; R D Gascoyne; M J Barnett; T J Nevill; J D Shepherd; S H Nantel; H J Sutherland; D L Forrest; D E Hogge; J C Lavoie; Y R Abou-Mourad; M Chhanabhai; N J Voss; R R Brinkman; C A Smith; C L Toze
Journal:  Bone Marrow Transplant       Date:  2008-08-11       Impact factor: 5.483

4.  Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors.

Authors:  H Glucksberg; R Storb; A Fefer; C D Buckner; P E Neiman; R A Clift; K G Lerner; E D Thomas
Journal:  Transplantation       Date:  1974-10       Impact factor: 4.939

5.  Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect.

Authors:  A Dodero; F Spina; F Narni; F Patriarca; I Cavattoni; F Benedetti; F Ciceri; D Baronciani; R Scimè; E Pogliani; A Rambaldi; F Bonifazi; S Dalto; B Bruno; P Corradini
Journal:  Leukemia       Date:  2011-09-09       Impact factor: 11.528

Review 6.  Transplantation for non-Hodgkin lymphoma.

Authors:  Auayporn Nademanee
Journal:  Expert Rev Hematol       Date:  2009-08       Impact factor: 2.929

7.  Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens.

Authors:  H Bertz; G Illerhaus; H Veelken; J Finke
Journal:  Ann Oncol       Date:  2002-01       Impact factor: 32.976

8.  Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation.

Authors:  Charalampia Kyriakou; Carmen Canals; Jürgen Finke; Guido Kobbe; Jean-Luc Harousseau; Hans-Jochem Kolb; Nicolas Novitzky; Anthony H Goldstone; Anna Sureda; Norbert Schmitz
Journal:  J Clin Oncol       Date:  2009-07-20       Impact factor: 44.544

9.  Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes.

Authors:  Koen van Besien; Jeanette Carreras; Philip J Bierman; Brent R Logan; Arturo Molina; Roberta King; Gene Nelson; Joseph W Fay; Richard E Champlin; Hillard M Lazarus; Julie M Vose; Parameswaran N Hari
Journal:  Biol Blood Marrow Transplant       Date:  2009-03-09       Impact factor: 5.742

10.  Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.

Authors:  Paolo Corradini; Anna Dodero; Francesco Zallio; Daniele Caracciolo; Marco Casini; Marco Bregni; Franco Narni; Francesca Patriarca; Mario Boccadoro; Fabio Benedetti; A Rambaldi; Alessandro M Gianni; Corrado Tarella
Journal:  J Clin Oncol       Date:  2004-06-01       Impact factor: 44.544
View more
  1 in total

Review 1.  Mature lymphoid malignancies: origin, stem cells, and chronicity.

Authors:  Simon Husby; Kirsten Grønbæk
Journal:  Blood Adv       Date:  2017-11-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.